| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | -0.15 | 0.0005 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0005 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.15 | 0.0005 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0006 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0006 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0006 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0006 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | -0.15 | 0.0006 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0006 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0007 |